| Wayne Community Health Centers Inc | |
|
128 S 300 W Bicknell UT 84715 | |
| (435) 425-3744 | |
| (435) 425-3785 |
| Full Name | Wayne Community Health Centers Inc |
|---|---|
| Speciality | Clinic/Center |
| Location | 128 S 300 W, Bicknell, Utah |
| Authorized Official Name and Position | Darci Elmer (BILLING MANAGER) |
| Authorized Official Contact | 4354251104 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Wayne Community Health Centers Inc Po Box 303 Bicknell UT 84715-0303 Ph: (435) 425-3744 | Wayne Community Health Centers Inc 128 S 300 W Bicknell UT 84715 Ph: (435) 425-3744 |
| NPI Number | 1093816282 |
|---|---|
| Provider Enumeration Date | 09/26/2006 |
| Last Update Date | 11/07/2023 |
| Medicare PECOS PAC ID | 1254242233 |
|---|---|
| Medicare Enrollment ID | O20040113000649 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093816282 | NPI | - | NPPES |
| Provider Name | Todd Stanley Mooney |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1013024330 PECOS PAC ID: 3577461623 Enrollment ID: I20031227000013 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Leland J Chappell |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1447351424 PECOS PAC ID: 4587557269 Enrollment ID: I20040205000971 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | David M Pope |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1467554451 PECOS PAC ID: 8022901701 Enrollment ID: I20040205000984 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Mitchell Ray Miller |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1659480887 PECOS PAC ID: 8123028990 Enrollment ID: I20061228000397 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Daniel C Smith |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1669672366 PECOS PAC ID: 2668546821 Enrollment ID: I20080806000194 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Justin D Abbott |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1184814436 PECOS PAC ID: 5890850523 Enrollment ID: I20090212000712 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | David Jack Watkins |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1649283979 PECOS PAC ID: 2062427818 Enrollment ID: I20100929000477 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Sherree C Rechtsteiner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831387679 PECOS PAC ID: 7012191752 Enrollment ID: I20110405000372 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Matthew B Barney |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1124313507 PECOS PAC ID: 9931376407 Enrollment ID: I20120124000634 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Bart Tiberius Hunter |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437383932 PECOS PAC ID: 1557582384 Enrollment ID: I20150309000481 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Cole W Robinson |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1871799528 PECOS PAC ID: 5890012116 Enrollment ID: I20150714000690 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Theron A Draper |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1679874580 PECOS PAC ID: 2668774381 Enrollment ID: I20160112001160 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Dixie Rasmussen |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1740385046 PECOS PAC ID: 3476876459 Enrollment ID: I20170501002051 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Sadie Christine Dahlsrud |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1497040356 PECOS PAC ID: 2769737790 Enrollment ID: I20180615001072 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Deann Robinson Brown |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1497863393 PECOS PAC ID: 8729119631 Enrollment ID: I20190516002078 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Nathaniel M Barusch |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1548648520 PECOS PAC ID: 3375879653 Enrollment ID: I20190724001587 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Tonya Coates |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902448236 PECOS PAC ID: 1951720325 Enrollment ID: I20201005000917 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Joshua Truman Chapman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790378917 PECOS PAC ID: 4082021514 Enrollment ID: I20210330002514 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Chad R Cottam |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1720551617 PECOS PAC ID: 9739596842 Enrollment ID: I20210407001255 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Mckenzie Ree Ellett |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164119160 PECOS PAC ID: 7719342724 Enrollment ID: I20230426002605 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Robert Michael Peyton |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1609083716 PECOS PAC ID: 9436501004 Enrollment ID: I20240118004033 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
| Provider Name | Korin K Richins |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1831568351 PECOS PAC ID: 1153765987 Enrollment ID: I20240220001565 |
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago
News Archive
As more and more complaints continue to appear regarding the behaviour of a Sydney doctor many are appalled that he continued to practice after being struck off the medical register.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The concept of the recent study is already presented in the conference materials issued by the French publishing house Atlantis Press, indexed by the Scopus and Web of Science databases. Externally, the "smart" chair is no different from the standard one. The difference is that it is equipped with special sensors that detect a person's posture and forewarn him when he is sitting incorrectly.
Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.
› Verified 8 days ago